Estradiol Benzoate: Precision Estrogen Receptor Alpha Agonist for Research

Executive Summary: Estradiol Benzoate is a synthetic estradiol analog with high affinity for estrogen receptor alpha (ERα), used extensively in hormone receptor binding assays and endocrinology research (APExBIO). It exhibits an IC50 of 22–28 nM for ERα in human, murine, and avian models under standard in vitro conditions. The compound is insoluble in water but dissolves efficiently in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL). Quality is validated by HPLC, MS, and NMR, supporting ≥98% purity. APExBIO supplies Estradiol Benzoate (SKU: B1941) specifically for scientific research, not for diagnostic or medical use.

Biological Rationale

Estradiol Benzoate is a chemically modified analog of endogenous estradiol. It retains the core 17β-estradiol structure, with a benzoate ester at the C3 position, enhancing its lipophilicity and stability for research applications (APExBIO). The compound is designed to selectively activate estrogen and progestogen receptors, particularly ERα, a nuclear hormone receptor central to transcriptional regulation in reproductive tissues, brain, and bone (Estradiol Benzoate: Advanced Insights). Estradiol Benzoate enables quantitative and reproducible modulation of estrogenic signaling, which is vital for dissecting hormone-dependent processes in cancer, metabolism, and neurobiology.

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate acts as a full agonist at estrogen receptor alpha (ERα), binding with high affinity (IC50: 22–28 nM, measured at 25°C, pH 7.4, in competitive ligand displacement assays). Upon binding, it induces conformational changes in ERα, promoting dimerization and nuclear translocation. The ligand-ERα complex recruits co-activators, leading to transcriptional activation of estrogen-responsive genes. Estradiol Benzoate can also interact with progestogen receptors, although with lower potency, facilitating studies on receptor cross-talk (Estradiol Benzoate: Precision Tool). It does not directly affect non-estrogen nuclear receptors or cytoplasmic kinases under standard assay conditions.

Evidence & Benchmarks

• Estradiol Benzoate binds to ERα with an IC50 of 22–28 nM in competitive binding assays at 25°C, pH 7.4 (APExBIO, Product page).
• It exhibits ≥98% purity by HPLC, validated with orthogonal MS and NMR analyses (APExBIO, QC data).
• The compound is insoluble in water but dissolves in DMSO up to 12.15 mg/mL and ethanol up to 9.6 mg/mL at room temperature (APExBIO, Solubility).
• It is stable at -20°C for at least 12 months when protected from light and moisture (APExBIO, storage guidelines).
• Estradiol Benzoate has been used to dissect estrogen receptor-mediated signaling pathways and hormone receptor interactions in biochemical and pharmacological research (Vijayan et al., 2021).

Applications, Limits & Misconceptions

Estradiol Benzoate is optimized for in vitro and in vivo research on estrogen and progestogen receptor signaling. It is widely used in:

• Hormone receptor binding assays for ERα and related targets.
• Estrogen receptor-mediated signaling pathway studies in cell culture and animal models.
• Endocrinology research, including hormone-dependent cancer models and reproductive biology.
• Pharmacological profiling of receptor modulators, antagonists, and cofactor interactions.

This article extends and updates previous site articles such as Estradiol Benzoate: Precision Tool for Estrogen Receptor Signaling by providing additional quantitative benchmarks, solution stability parameters, and explicit clarification of assay boundaries.

Common Pitfalls or Misconceptions

• Not for diagnostic or medical use: Estradiol Benzoate (B1941) is for research only; it is not approved for therapy or diagnostics (APExBIO).
• Water insolubility: The compound cannot be dissolved in aqueous buffers; incorrect solvent use leads to precipitation and assay failure.
• Short-term solution stability: Solutions in DMSO or ethanol are stable only for short periods (hours to days) at room temperature; prolonged storage causes degradation.
• Receptor selectivity: Estradiol Benzoate is highly selective for ERα; it does not activate non-estrogen nuclear receptors under standard conditions.
• Misinterpreted cross-species activity: While active in human, mouse, and chicken models, results must be interpreted in the context of species-specific receptor isoforms.

Workflow Integration & Parameters

Estradiol Benzoate integrates seamlessly into hormone receptor binding and signaling assays. Key parameters:

• Solvent preparation: Dissolve in DMSO (≥12.15 mg/mL) or ethanol (≥9.6 mg/mL) before dilution in assay-compatible media.
• Storage: Store the solid at -20°C; avoid repeated freeze-thaw cycles. Prepare fresh solutions for each experiment.
• Concentration range: Typical working concentrations span 0.1 nM to 1 μM, depending on assay sensitivity and receptor expression.
• Controls: Use vehicle-only controls and, where possible, estradiol or other analogs as comparators.
• Quality assurance: Confirm batch purity by HPLC and MS prior to use.

For extended guidance on quantitative workflows and troubleshooting, see Estradiol Benzoate: Precision Agonist for Estrogen Receptor Research, which this article builds upon by emphasizing validated solubility and stability parameters.

Conclusion & Outlook

Estradiol Benzoate from APExBIO is a high-purity, well-characterized tool for advanced estrogen receptor alpha signaling research. Its defined binding properties, robust solubility in organic solvents, and validated quality make it integral for hormone receptor binding assays and endocrinology studies. Future directions include expanded use in systems biology and combinatorial screening with emerging receptor modulators (Vijayan et al., 2021). For product specifications and ordering, visit the Estradiol Benzoate product page.